Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer

Author： Obinata Daisuke   Takayama Kenichi   Takahashi Satoru   Inoue Satoshi  

Publisher： MDPI

E-ISSN： 2072-6694|9|3|22-22

ISSN： 2072-6694

Source： Cancers, Vol.9, Iss.3, 2017-02, pp. : 22-22

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen Receptor Coregulatory Proteins as Potential Therapeutic Targets in the Treatment of Prostate Cancer

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite

New Therapeutic Strategies for Castration-Resistant Prostate Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 373-383

Bentham Science Publishers

Access to resources Recommend Favorite

Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage

By Li Lei  

Carcinogenesis, Vol. 34, Iss. 2, 2013-02 ,pp. : 257-267

Oxford University Press

Access to resources Recommend Favorite

CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells

By                                    

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1560-1572

Spandidos Publications

Access to resources Recommend Favorite

Molecular mechanisms of castration-resistant prostate cancer progression

By Dutt Smitha S   Gao Allen C  

Future Oncology, Vol. 5, Iss. 9, 2009-11 ,pp. : 1403-1413

Future Medicine

Access to resources Recommend Favorite